drugset / Trial / NCT00057681

Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents

NCT00057681

RandomizedParallel-groupOpen-labelTreatment

Summary

This study will evaluate the effectiveness of the medications, lithium (Eskalith®), valproate (Depakote®), and risperidone (Risperdal®) in treating children and adolescents with bipolar disorder or symptoms of mania.

Timeline

Start
2003-02
Primary completion
2008-12
Completion
2008-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lithium Carbonate Unknown
Subject Risperidone Other / unclassified 2 mg
Subject Risperidone Other / unclassified 3 mg
Subject Valproate Small molecule

Indications